TG Therapeutics, Inc. (LON:0VGI)
37.50
-1.05 (-2.72%)
At close: Mar 14, 2025
TG Therapeutics Revenue
TG Therapeutics had revenue of $120.86M USD in the quarter ending March 31, 2025, with 90.40% growth. This brings the company's revenue in the last twelve months to $386.39M, up 33.54% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.
Revenue (ttm)
$386.39M
Revenue Growth
+33.54%
P/S Ratio
12.80
Revenue / Employee
$1.14M
Employees
338
Market Cap
3.83B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 329.00M | 95.34M | 40.80% |
Dec 31, 2023 | 233.66M | 230.88M | 8,290.02% |
Dec 31, 2022 | 2.79M | -3.90M | -58.36% |
Dec 31, 2021 | 6.69M | 6.54M | 4,300.66% |
Dec 31, 2020 | 152.00K | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Indivior | 905.57M |
TG Therapeutics News
- 8 days ago - Lightning Round: Buy anything uranium, says Jim Cramer - CNBC
- 8 days ago - Cramer's Lightning Round: TG Therapeutics is a buy - CNBC
- 11 days ago - TG Therapeutics: Strong Execution Tempered By An Evolving Market - Seeking Alpha
- 13 days ago - TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel - Seeking Alpha
- 22 days ago - Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Benzinga
- 4 weeks ago - TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - TG Therapeutics: Estimates Could Soon Be Raised Again - Seeking Alpha
- 6 weeks ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire